Get caught up quickly on the top news and calls moving stocks with these Top Fives, as compiled by the editors of The Fly. 

1. STOCK NEWS: 

• IAC's (IAC) Dotdash will acquire Meredeith's (MDP) National Media Group for $42.18 per share [more]
• Twitter (TWTR) will sell MoPub to AppLovin (APP) for $1.05B in cash [more]
• Pfizer (PFE) and BioNTech (BNTX) officially submitted an EUA request to the FDA for their COVID-19 vaccine for children [more]
• Citrix (CTXS) named Bob Calderoni as its interim CEO and updated its Q3 revenue guidance [more]
• Funds managed by Blackstone Capital (BX) signed a definitive agreement with EQT VII fund and KHF to acquire a majority stake in VFS Global [more]

2. WALL STREET CALLS:

• Square (SQ) assumed with Buy from Hold at Jefferies [more]
• Goldman upgrades Nio (NIO) to Buy on ET7's potential, sees 65% upside [more]
• Morgan Stanley upgrades Five Below (FIVE) to Overweight on "overblown" concerns [more]
• MoffettNathanson upgrades AT&T (T) to Neutral after "blood-letting"' of shares [more]
• Pinnacle West (PNW) downgraded to Sell from Buy at Guggenheim [more]

3. AROUND THE WEB:

• Emerson (EMR) is in talks over a potential tie-up with Aspen Technology (AZPN), Bloomberg says [more]
• Short seller Bear Cave sees "problems" at Joint Corp. (JYNT) [more]
• Apple (AAPL) is developing technology to expand its reach within cars, Bloomberg reports [more]
• Apple and Google (GOOGL) will be investigated by Japan's antitrust watchdog, Nikkei says [more]
• Faraday Future (FFIE) was named as a short idea by J Capital Research [more]

4. MOVERS:

• Rocket Lab (RKLB) rises after announcing that it has been selected to launch NASA's Advanced Composite Solar Sail System, or ACS3, on the Electron launch vehicle [more]
• Merus (MRUS) jumps after presenting early clinical data on MCLA-158 [more]
• New Fortress (NFE) higher after Scotiabank analyst Alonso Guerra-Garcia said the stock should be bought ahead of earnings [more]
• Osmotica Pharmaceuticals (OSMT) falls after a 14M share spot secondary priced at $2.50 [more]
• NeuroRx (NRXP) lower after Relief Therapeutics (RLFTF) announced that it has filed a lawsuit against the company and its CEO, Jonathan Javitt, for multiple breaches of the collaboration agreement between Relief and NeuroRx relating to the development and commercialization of RLF-100 [more]

5. EARNINGS/GUIDANCE:

• Conagra Brands (CAG) reaffirmed its FY22 adjusted earnings guidance [more]
• Levi Strauss (LEVI) reported upbeat Q3 results [more]
• Resources Connection (RGP) also reported upbeat quarterly results [more]
• Lamb Weston (LW) reported downbeat Q1 results [more]
• Tilray (TLRY) reported largely in-line Q1 results [more]

INDEXES:

The Dow rose 337.95, or 0.98%, to 34,754.94, the Nasdaq gained 152.10, or 1.05%, to 14,654.02, and the S&P 500 advanced 36.21, or 0.83%, to 4,399.76.